Using genome-wide expression profiles of breast cancers and normal human tissues [8,9], we identified MELK, one of the transcripts of which was specifically up-regulated in the great majority of clinical breast cancer samples, but expressed in none of 29 normal human tissues examined except testis, thymus and small intestine. This evidence concerns the gene MELK and breast carcinoma.